WebMar 30, 2024 · We performed a single-institution retrospective cohort study on adults with head and neck cancer treated with cisplatin and radiation therapy who participated in an ototoxicity monitoring program. The primary outcomes were rates of post-treatment audiograms at the following time points: one, three, six, 12, and greater than 12 months.
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck …
WebAbstract Objectives: Cisplatin-induced ototoxicity is a common permanent consequence of curative chemoradiation for locally advanced head and neck squamous cell carcinoma (HNSCC). Predictors of ototoxicity in HNSCC were examined. WebSep 3, 2024 · Cisplatin-based chemoradiation for locally advanced HPV-positive head and neck cancer has substantial long-term toxicity. To combat this, there’s been a significant effort to de-escalate treatment, … hills phys sacramento primed inc
Postoperative Concurrent Radiotherapy and …
WebJun 28, 2024 · According to results from two clinical trials published in The New England Journal of Medicine, the addition of the chemotherapy agent cisplatin (Platinol®) to … WebDec 13, 2016 · A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer (BMX-HN) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for … WebApr 11, 2024 · Methods and analysis: Patients have pathologically confirmed HNC and an intended regimen of 70 Gy of radiation with concurrent cisplatin. The protocol is initiated on diagnosis of grade 3 mucositis and consists of 2 weeks of 4 times daily (QID) ketamine mouthwash use. hills physician my chart